EZH2 and type 1 diabetes mellitus: Subsequent evaluation of CK19+ve cells derived from juvenile T1D (Fig. 1e), adult T1D (Fig. 1f) and adult non-diabetic (Fig. 1g) donors show pharmacological EZH2 inhibition influences the transcriptional expression of endocrine markers.